S

Sight Sciences, Inc. (SGHT)

NMS – Real vaqt narxi. Valyuta: USD

4.93

-0.38 (-7.16%)

Yopilishda: May 12, 2026, 4:00 PM EDT

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz haqimizda

Biz bilan bog'lanish

[email protected]

Bizni kuzating

Barcha huquqlar himoyalangan.

Foydalanish shartlari

S

Sight Sciences, Inc. (SGHT)

NMS – Real vaqt narxi. Valyuta: USD

4.93

-0.38 (-7.16%)

Yopilishda: May 12, 2026, 4:00 PM EDT

07.05.2026

Sight Sciences, Inc. (SGHT) Q1 2026 Earnings Call Transcript

07.05.2026

Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Sight Sciences (SGHT) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

06.05.2026

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates

Sight Sciences, Inc. (SGHT) came out with a quarterly loss of $0.16 per share versus the Zacks Consensus Estimate of a loss of $0.19. This compares to a loss of $0.28 per share a year ago.

06.05.2026

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.

29.04.2026

Sight Sciences to Present at Two Upcoming Investor Conferences

MENLO PARK, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced plans to present at two upcoming conferences.

22.04.2026

Sight Sciences Announces the Release of its Sustainability Report

The Sustainability Report provides data for 2023 through 2025 on the Company's environmental, social, and governance initiatives The Sustainability Report provides data for 2023 through 2025 on the Company's environmental, social, and governance initiatives

21.04.2026

Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026

MENLO PARK, Calif., April 21, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced it will report financial results for the first quarter ended March 31, 2026, after the market close on Wednesday, May 6, 2026. The Company's management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.

Videolar

No Data

There is no data to display

Press-relizlar

06.05.2026

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

MENLO PARK, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) ("Sight Sciences" or the "Company"), an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today reported financial results for the first quarter ended March 31, 2026 and raised its revenue guidance for full year 2026.

22.04.2026

Sight Sciences Announces the Release of its Sustainability Report

The Sustainability Report provides data for 2023 through 2025 on the Company's environmental, social, and governance initiatives The Sustainability Report provides data for 2023 through 2025 on the Company's environmental, social, and governance initiatives

$Sight Sciences' Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting$

01.04.2026

Sight Sciences' Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

MENLO PARK, Calif., April 01, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional technologies intended to transform care and improve patients' lives, today announced that data on two of its proprietary glaucoma and dry eye technologies, the OMNI® Surgical System and the TearCare® System, will be presented at this year's ASCRS Annual Meeting held in Washington, DC.

30.03.2026

Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury's Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent

Court preserves jury's finding of willful infringement by Alcon, and awards past damages to Sight Sciences in excess of $34 million and ongoing royalties through November 2028 Court preserves jury's finding of willful infringement by Alcon, and awards past damages to Sight Sciences in excess of $34 million and ongoing royalties through November 2028

Search stocks

Sight Sciences, Inc. (SGHT)

Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling

Finranks

Kompaniya

Biz bilan bog'lanish

Bizni kuzating

Sight Sciences, Inc. (SGHT)

Sight Sciences, Inc. (SGHT) Q1 2026 Earnings Call Transcript

Sight Sciences (SGHT) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Beats Revenue Estimates

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

Sight Sciences to Present at Two Upcoming Investor Conferences

Sight Sciences Announces the Release of its Sustainability Report

Sight Sciences to Report First Quarter 2026 Financial Results on May 6, 2026

Videolar

No Data

Press-relizlar

Sight Sciences Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Revenue Guidance

Sight Sciences Announces the Release of its Sustainability Report

Sight Sciences' Interventional Technologies for Glaucoma and Dry Eye Disease to be Featured in Multiple Clinical Presentations at the 2026 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Sight Sciences Secures Order on Post-Trial Motions That Preserves the Jury's Verdict and Awards Monetary Damages to Sight Sciences Against Alcon and its Hydrus® Microstent